In this study, we compared two different D 
F]desmethoxyfallypride ([ 18 F]DMFP) with respect to the duration of the scan, visualization of extrastriatal receptors, and binding potentials (BP ND ) in the rat brain. In addition, we studied the feasibility of using these tracers following a period of awake tracer uptake, during which the animal may perform a behavioral task. Male Sprague-Dawley rats were imaged with [ For the test-retest studies, BP ND was measured using both Logan noninvasive (LNI) method and the interval ratios (ITR) method. Cerebellum was used as a reference region. For the third study, the binding was measured only with the ITR method, and the results were compared to the baseline results. Studies showed that the average transient equilibrium time in the dorsal striatum (DSTR) was at 90 min for [ (Patel et al., 2008) . For this to be possible, the animals need to be awake, while at the same time allow the dopaminergic system to be altered while monitored using the D2/D3 radioligands. Using high affinity and displaceable radioligands labeled with 18 F, would allow sufficient time for the task and measurement.
[
18 F]Fallypride is a highly selective dopamine D 2/3 receptor radioligand that has been shown to yield high specific/nonspecific ratios in nonhuman primates in vivo (Christian et al., 2000) . [
18 F]Fallypride is of interest because of its high affinity for both striatal and extrastriatal binding, which has been demonstrated in studies of nonhuman primates and humans (Christian et al., 2000 (Christian et al., , 2002 (Christian et al., , 2004 Mukherjee et al., 2002; Slifstein et al., 2004a) . It has also been shown that it responds to amphetamine-induced dopamine release (Mukherjee et al., 2005; Slifstein et al., 2004a) . Rodent imaging studies using [ 18 F]fallypride have recently been reported (Tantawy et al., 2009 (Grunder et al., 2003; Mukherjee et al., 1996; Siessmeier et al., 2005) . Recent microPET studies in mice (Rominger et al., 2010) F]DMFP binding in rats using dynamic PET and compare the two agents under baseline conditions. In addition, we performed PET scans in which the animals were allowed to be awake for a period of time between tracer injection and start of the scan and compared the results (binding) to those with animals under anesthesia for the whole duration of the experiment. Last, we evaluated the dissociation of both tracers in vivo in response to pharmacological intervention with haloperidol, a dopamine D2/D3 receptor antagonist.
As the collection of blood samples from small animals is often difficult, we limited our methodology to a practical approach used by majority of researchers in preclinical PET, which is using noninvasive methods for calculations of binding potentials (BP ND ). We used Logan plot analysis as well as an interval method (ITR) based on tissue ratios. Both methods rely on tracer achieving transient equilibrium following a bolus injection, a state in which blood-tissue distribution volumes in target and reference regions become equal. The reference brain region, which in our case was cerebellum, is assumed to have a minimal presence or a lack of D 2/3 receptors.
MATERIALS AND METHODS
Tracer synthesis F-fluoropropyl)-2-methoxybenzamide) was synthesized as reported in Mukherjee et al. (1995 Mukherjee et al. ( , 1996 , with a 12-h light cycle. During housing, subjects had free access to food and water. Subjects were fasted in the imaging room in a dark quiet place for 4-6 h before experiments. In preparation for the scans, the rats were anesthetized with isoflurane and then maintained under anesthesia during the scan (4% induction and 2.5% maintenance). The anesthesia line was attached to the animal via a nose cone. The temperature of the animal was maintained constant with a water-circulating heating pad attached. Data were acquired using an Inveon dedicated PET scanner for small animals (Siemens Medical Solutions, Knoxville, TN) with a transaxial FWHM of 1.5 mm and axial FWHM of 1.3 mm (Bao et al., 2009; Constantinescu and Mukherjee, 2009) . A 350-650 keV photon energy window and 3.43-ns timing window were used for data acquisition. The list-mode data were rebinned into 3D sinograms of span 3 and ring difference 79. The data from 150-min acquisition was histogrammed in 41 time frames (10 3 1 min, 5 3 2 min, and 26 3 5 min), and the data from 90 min acquisition was histogrammed into 18 frames of 5 min each. Random events were subtracted before reconstruction. The images were reconstructed using Fourier rebinning and two-dimensional filtered backprojection (2D FBP) method (ramp filter and cutoff at Nyquist frequency) with an image matrix of 128 3 128 3 159, resulting in a pixel size of 0.77 mm and a slice thickness of 0.796 mm. All dynamic images were corrected for radioactive decay. Attenuation correction was performed using a 10-min transmission scan with a 57 Co point source prior to tracer injection. In the case of awake uptake experiments, the transmission acquisition was performed following the emission scan. Normalization of detector responses was also applied using a cylinder source inversion method.
Image analysis
Processing of reconstructed images was performed with PMOD software package (PMOD Technologies). MicroPET images were normalized to the standard space described by the stereotaxic coordinates of Paxinos and Watson (1982) via coregistration to an MRI rat template (Schweinhardt et al., 2003) . The size of the template image was 80 3 63 3 108 voxels with a voxel size of 2 mm. The template includes a scale factor of 10 in order to roughly match the size of the human brain and facilitate analysis with SPM software. Bregma was set as the origin of coordinates system. The spatial extent of the template volume (bounding box) was from 280 to 80 mm in X direction (left to right of the midline, through the sagital planes), 2120 to 6 mm in the Y direction (ventral to dorsal, through the horizontal planes), and from 2156 to 60 mm in the Z direction (posterior to anterior, through the coronal planes).
Standard 3D volumes of interest (VOIs) were drawn on the MR template for dorsal striatum (DSTR), ventral striatum (VSTR), colliculi (COL), substantia nigra/ventral tegmental area (SN/VTA), central gray (CG), and cerebellum (CER). The location of the VOIs was confirmed by examination of the Paxinos and Watson rat atlas (4th edition). The size of each predefined VOI was smaller than actual anatomical extent of the brain structure in order to avoid the negative effects of spillover. The VOIs over DSTR and VSTR consisted of pair of spheres with 2 mm diameter and placed symmetrically with respect to the midline. The sphere centers in template coordinates with respect to bregma were (x,y,z) 5 (628, 248, 4) mm for right\left DSTR and (x,y,z) 5 (615, 276, 14) mm for right\left VSTR. For the extrastriatal structures, the VOIs consisted of a series of ellipses (2D) placed on multiple coronal planes, with the centers of mass at (614, 238, 270) mm (right\left superior COL), (619, 239, 288) mm (right\left inferior COL), (621, 277, 254) mm, (621, 277, 288) (right\left SN) mm, (68, 277, 259) mm (right\left VTA), and (21, 252, 269) mm (CG). The superior and inferior COL were combined into a single COL VOI as well as SN with VTA into a single SN/VTA VOI. The cerebellum VOI consisted of two ellipsoids placed on lateral lobes and centered at (629, 243, 2128) mm with a long axis of 3 mm and a short axis of 2 mm. The left and right VOIs for each structure were combined into a single VOI.
The dynamic PET images were first summed, and the sum image was resliced using the Fusion toolbox of PMOD to match the size of the template. All sum images were subjected to a common initial spatial transformation consisting of a scale factor (zoom) of 10 and a rotation of 1808 around the z axis, so that the orientation of the brain to roughly match the orientation of the MR brain template. Through subsequent rigid transformations (translations and rotations) applied to each sum image, the brain was coregistered to match the template and therefore the Paxinos atlas. The resulted transformation matrix for each subject was subsequently applied to all the images in the dynamic series. Time activity curves (TACs) were extracted for each VOI from the dynamic PET data.
Kinetic analysis
Kinetic analysis was performed using a specialized PMOD toolbox. BP ND was calculated using Logan noninvasive (LNI) method (Logan et al., 1996) . BP ND (5''DVR-1'') was estimated graphically from the equation
where C t (t) is the time-dependent tracer concentration within the region with specific binding, and
is the tracer concentration within the region devoid of binding sites (i.e., cerebellum). DVR is the distribution volume ratio, k 2 0 (min
21
) is the transfer rate between the free and plasma for cerebellum. int 0 is the intercept of the linear plot. At the time when the change in the target region equals that in the reference region (pseudo equilibrium), the slope (DVR) becomes constant and can be estimated from a simple linear fit. Before linear regression in (1), the average rate k 2 0 for cerebellum was estimated from fitting the simplified reference tissue model (SRTM) (Lammertsma and Hume, 1996) to the first 90 min of data from a region placed on the whole striatum. Striatum was used for the SRTM fit due the expected high binding and therefore low-statistical noise. The model equation for SRTM is
where R 1 (5K 1 /K 1 0 ) is the relative tracer delivery between the target and reference region. R 1 , k 2 , and BP ND are the only parameters estimated directly while k 2 0 (5k 2 /R 1 ) is derived based on the assumption that K 1 /k 2 5 K 1 0 /k 2 0 . K 1 and K 1 0 are the tracer delivery rates to the target and to the reference region, respectively, and k 2 is the tissue-to-plasma clearance rate for the target region. For SRTM fitting, Marquandt optimization method with 200 iterations was used. The estimated k 2 0 for each subject was then fixed and used subsequently for Logan analysis of all other brain regions. The cutoff of Logan plot was determined based on a preset error of 10% between the fit and the data. The LNI method was used only in Studies 1 and 2 for which full TACs were available for analysis.
To evaluate the BP in the Study 3, in which full TACs were not available, we used an ITR (Ito et al., 1998) instead of LNI method, which generally requires data from time 0. BP ND was estimated as
where
is the specific binding curve. The curves were integrated between t S (560 min) and t E (5150 min). For comparison, the ITR method was applied to data from Studies 1 and 2 as well. For Study 4 with haloperidol administration, we evaluated the in vivo dissociation constant by assuming the TAC posthaloperidol as being described by a exponential with the fall-off constant given by the dissociation constant, k off . Following haloperidol injection, the tissue-specific binding curve can be expressed as (Fig. 1) showed high tracer uptake to both striatal (DSTR and VSTR) and extrastriatal regions (SN/VTA, COL, and CG) and very low binding in the cerebellum. In the case of [ ) are the transfer rates between the free compartment and plasma for cerebellum estimated as a derived parameter using SRTM. In the case of [
18 F]DMFP, the BP ND values of the two animals that underwent Study 3 (awake uptake for 60 min) were 2.6 times higher in DSTR (1.8 in VSTR) than those from the control studies performed entirely under anesthesia.
The effects of haloperidol administered at 90 min ([ Figures 2B and 2D as well as in Figure 6 . For both tracers, we note the fast drop in activity due to haloperidol blockage of the receptor sites. Both striatal and extrastriatal regions F]fallypride computed with LNI method was in the interval 15-20% for al regions. When the ITR method was used, the variability was much larger, up to 30%. However, the variability should be low enough to be exceeded by changes in occupancy due to drugs such as amphetamine, which in PET studies on baboons has been shown to cause changes in binding close to 50% in the striatum (Slifstein et al., 2004b) . This shows that in group studies with drugs that cause dopamine release or block the dopamine reuptake, it is possible to exceed the threshold of detectability of the respective drugs' effects. It is important to note that we used filtered-back projection to reconstruct the images. Iterative reconstruction methods such as the ordered subsets expectation maximization has been shown to markedly improve the test-retest variability of BP ND measurements (Catafau et al., 2008 (Rominger et al., 2010) . Similar studies need to be performed in rats in order to quantitatively evaluate changes in the [ The integration interval for the ITR method has to include the time of transient equilibrium. For the purpose of comparing Study 3 with the control, we opted for a fixed time interval (60-150 min). However, this interval does not include the time of transient equilibrium, especially for the extrastriatal regions with a lower receptor density than striatum.
As discussed in Carson et al. (1993) and Slifstein (2008) , caution must be exercised when using the ITR with late in the scan integration times as the bias with respect to the ''gold standard,'' that is, BP ND calculated with kinetic modeling and plasma input function method, depends on the peripheral clearance of radioligand.
Both F]DMFP in the VSTR was comparable in magnitude to that in DSTR. The examination of TACs after haloperidol showed that the concentration of tracer in VSTR is maintained at a level above that in the DSTR (Fig. 2D) . Because haloperidol blocks more or less nonselectively both D2 and D3 varieties of receptors (Kulagowski et al., 1996) , this observation points to a higher degree of nonspecific binding in VSTR compared to the DSTR. The large fraction of nonspecific binding by [ 18 F]DMFP has been suggested by the studies in humans (Grunder et al., 2003) . One can also speculate that the relative affinity of DMFP for D3 receptors with respect to haloperidol is much higher than that for D2 receptors. In vitro mice studies have shown predominant localization of D3 receptors in that nucleus accumbens/VSTR (Bouthenet et al., 1991) . Although our study does not provide the tools to support such a hypothesis, further investigation with D3 selective antagonists may be designed to differentially evaluate the occupancy of D3 versus D2 receptors in rat brain.
18 F]Fallypride uptake in awake rats followed by late isoflurane anesthesia did not cause significant change in the estimated BP ND compared to the case of full scan under anesthesia. This shows that behavioral experiments could be designed to take place during the initial tracer uptake period, followed by a 60-min scan, and the results compared to control studies performed under anesthesia. The experimental procedure could be refined by preparation of animals through implantation of a catheter for tracer delivery in advance, so that the animals could be maintained awake for the entire period between tracer administration and induction of anesthesia for the scan (Patel et al., 2008) . In our case, the animals were anesthetized briefly to allow the injection of tracer.
The 
